The expanded Pfizer facility in Singapore will produce “various small molecule APIs” for a range of drugs, including cancer drugs....
astrazeneca
Global pharmaceutical big AstraZeneca has introduced its plan to construct a USD 1.5 billion (SGD 2 billion) end-to-end manufacturing facility...